{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:48:00Z","timestamp":1768704480653,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":7892,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1054\/jpai.2002.27142","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T07:34:15Z","timestamp":1027668855000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["The use of botulinum toxin for the treatment of chronic facial pain"],"prefix":"10.1054","volume":"3","author":[{"given":"Gary E.","family":"Borodic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A.","family":"Acquadro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/jpai.2002.27142_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00000542-199403000-00041","article-title":"Treatment of myofascial pain with botulinum toxin","volume":"80","author":"Acquadro","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1054\/jpai.2002.27142_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","article-title":"Blepharospasm past, present and future","volume":"14","author":"Anderson","year":"1998","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1054\/jpai.2002.27142_bib3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM199604253341701","article-title":"The long term outcome of microvascular decompression for trigeminal neuralgia","volume":"334","author":"Barker","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1054\/jpai.2002.27142_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000116936","article-title":"Effectiveness of botulinum toxin in the treatment of spasmodic torticollis","volume":"33","author":"Boghen","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1054\/jpai.2002.27142_bib5","series-title":"Photophobia, an unrecognized component of the essential blepharospasm syndrome","author":"Borodic","year":"1996"},{"key":"10.1054\/jpai.2002.27142_bib6","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0140-6736(05)79896-2","article-title":"Myasthenia gravis after botulinum toxin","volume":"352","author":"Borodic","year":"1998","journal-title":"Lancet"},{"key":"10.1054\/jpai.2002.27142_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1517\/13543784.10.8.1531","article-title":"Botulinum toxin therapy for pain and inflammatory disorders: Mechanisms and therapeutic effects","volume":"10","author":"Borodic","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1054\/jpai.2002.27142_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00006534-198903000-00028","article-title":"Blepharospasm and its treatment with emphasis on the use of botulinum A toxin","volume":"83","author":"Borodic","year":"1989","journal-title":"Plast Reconstr Surg"},{"key":"10.1054\/jpai.2002.27142_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.46.1.26","article-title":"Botulinum toxin, immunologic resistance, and problems with available materials","volume":"46","author":"Borodic","year":"1996","journal-title":"Neurology"},{"key":"10.1054\/jpai.2002.27142_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00006534-199102000-00010","article-title":"Botulinum A toxin for adult onset spasmodic torticollis","volume":"87","author":"Borodic","year":"1991","journal-title":"Plast Reconstr Surg"},{"key":"10.1054\/jpai.2002.27142_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1468-2982.1995.1504277.x","article-title":"Neurogenic model for migraine","volume":"15","author":"Buzzi","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1054\/jpai.2002.27142_bib12","first-page":"127","article-title":"5-Hydroxytrytamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activiation within the rat dura mater after trigeminal stimulation","volume":"528","author":"Buzzi","year":"1992","journal-title":"Brain Res"},{"issue":"suppl 1","key":"10.1054\/jpai.2002.27142_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1054\/jpai.2000.9818","article-title":"Pain: Molecular mechanisms","volume":"1","author":"Costigan","year":"2000","journal-title":"J Pain"},{"key":"10.1054\/jpai.2002.27142_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199604253341709","article-title":"Treatment of trigeminal neuralgia","volume":"334","author":"Fields","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1054\/jpai.2002.27142_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1054\/bjom.1999.0238","article-title":"Botulinum toxin: New treatment for temporomandibular disorders","volume":"38","author":"Freund","year":"2000","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1054\/jpai.2002.27142_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.micro.53.1.551","article-title":"Clostridial toxins as therapeutic agents: Benefits of nature's most toxic proteins","volume":"53","author":"Johnson","year":"1999","journal-title":"Annu Rev Microbiol"},{"key":"10.1054\/jpai.2002.27142_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/archotol.125.6.627","article-title":"Long term enhancement of botulinum toxin injections by upper eyelid surgery in 14 patients with facial dyskinesia","volume":"125","author":"Mauriello","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1054\/jpai.2002.27142_bib18","first-page":"179","article-title":"Use of botulinum toxin in the treatment of cervical dystonia","volume":"2","author":"Poewe","year":"1993","journal-title":"Bailleres Clin Neurol"},{"key":"10.1054\/jpai.2002.27142_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","article-title":"Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study","volume":"40","author":"Rollnik","year":"2000","journal-title":"Headache"},{"key":"10.1054\/jpai.2002.27142_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0030-6665(20)31337-2","article-title":"Neural mechanisms of oral and facial pain","volume":"22","author":"Sessle","year":"1989","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1054\/jpai.2002.27142_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0091-6749(83)90085-4","article-title":"Exercise-induced anaphylaxis: A distinct form of physical allergy","volume":"71","author":"Sheffer","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1054\/jpai.2002.27142_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"key":"10.1054\/jpai.2002.27142_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM198003133021104","article-title":"Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria","volume":"302","author":"Soter","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1054\/jpai.2002.27142_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3171\/jns.1999.90.5.0828","article-title":"Trigeminal nerve peripheral branch phenol\/glycerol injections for tic douloureux","volume":"90","author":"Wilkinson","year":"1999","journal-title":"J Neurosurg"},{"key":"10.1054\/jpai.2002.27142_bib25","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1073\/pnas.96.14.7723","article-title":"Transcriptional and posttranslational plasticity and the generation of inflammatory pain","volume":"96","author":"Woolf","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1054\/jpai.2002.27142_bib26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: Aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1054\/jpai.2002.27142_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-2044.1999.00905.x","article-title":"Long term outcome of percutaneous thermocoagulation for trigeminal neuralgia","volume":"54","author":"Yoon","year":"1999","journal-title":"Anesthesia"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590002059540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590002059540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:37:51Z","timestamp":1761507471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590002059540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S1526590002059540"],"URL":"https:\/\/doi.org\/10.1054\/jpai.2002.27142","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of botulinum toxin for the treatment of chronic facial pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1054\/jpai.2002.27142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}